Actively Recruiting
A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor
Led by Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Updated on 2026-01-15
107
Participants Needed
1
Research Sites
101 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is being conducted to evaluate the pharmacokinetics , safety, tolerability and efficacy in patients with solid tumor.
CONDITIONS
Official Title
A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Confirmed solid tumor by histology or cytology
- Eastern Cooperative Oncology Group (ECOG) score of 0 or 1
- Expected survival of at least 12 weeks
- At least one measurable lesion based on RECIST v1.1 criteria
- Adequate kidney and liver function
- Voluntary participation with signed informed consent
You will not qualify if you...
- History of any cancer in the past 5 years except cured cervical carcinoma in situ and melanoma skin cancer
- Major surgery or chemotherapy/radiotherapy within 4 weeks before starting treatment
- History of immunodeficiency
- Significant cardiovascular disease
- Known or suspected interstitial lung disease
- Known bleeding or clotting disorders
- Active hepatitis or liver cirrhosis
- Allergy to any components of the study drug
- History of neurological or psychiatric disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China, 510000
Actively Recruiting
Research Team
Y
Yue Zhang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here